Clinical Trial Update: Post Marketing Surveillance of Remicade

View source ↗

Summary

The document reports the completion of a post-marketing surveillance study of Remicade (infliximab) in Korea assessing safety in Crohn's disease and ankylosing …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Crohn Disease

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Janssen Korea, Ltd., Korea | Conditions: Crohn's Disease, Ankylosing Spondylitis | Status: COMPLETED